{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:09:45Z","timestamp":1793106585138,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC 96-2314-B-006-018"],"award-info":[{"award-number":["NSC 96-2314-B-006-018"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","award":["NSC-97-2314-B-006-051-MY3"],"award-info":[{"award-number":["NSC-97-2314-B-006-051-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012537","name":"Ditmanson Medical Foundation Chia-Yi Christian Hospital","doi-asserted-by":"publisher","award":["95-01"],"award-info":[{"award-number":["95-01"]}],"id":[{"id":"10.13039\/501100012537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.urology.2008.11.060","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T05:17:24Z","timestamp":1250227044000},"page":"951-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic Relevance of Prothymosin-\u03b1 Expression in Human Upper Urinary Tract Transitional Cell Carcinoma"],"prefix":"10.1016","volume":"74","author":[{"given":"Yeong-Chin","family":"Jou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Liang","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Shyan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Huang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Syue-Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Li","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Tzu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shin","family":"Tzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2008.11.060_bib1","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2008.11.060_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.11.060_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","article-title":"Unusual clinical presentation of upper urothelial carcinoma in Taiwan","volume":"85","author":"Chou","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib4","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/cncr.22557","article-title":"Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan","volume":"109","author":"Chang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.07565.x","article-title":"Clinical and epidemiological features of patients with genitourinary tract tumour in a Blackfoot disease endemic area of Taiwan","volume":"102","author":"Tan","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2008.11.060_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","article-title":"Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients","volume":"54","author":"Li","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.11.060_bib7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1464-410X.2008.07438.x","article-title":"Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract","volume":"101","author":"Novara","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2008.11.060_bib8","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-5347(05)00057-1","article-title":"Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome","volume":"175","author":"Holmang","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.11.060_bib10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.urology.2005.06.117","article-title":"Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract","volume":"66","author":"Tsai","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.11.060_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European Centers","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.eururo.2008.01.006","article-title":"Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors","volume":"53","author":"Zigeuner","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.11.060_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0022-5347(01)66855-1","article-title":"Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis","volume":"154","author":"Terrell","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.11.060_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1995.14","article-title":"Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder","volume":"71","author":"Imai","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urology.2004.08.025","article-title":"HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique","volume":"65","author":"Langner","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.11.060_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<827::AID-CNCR20>3.0.CO;2-W","article-title":"The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract","volume":"78","author":"Chowdhury","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.11.060_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.urology.2007.12.029","article-title":"Correlation of COX-2 expression in stromal cells with high stage, high grade, and poor prognosis in urothelial carcinoma of upper urinary tracts","volume":"72","author":"Kang","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.11.060_bib18","first-page":"1863","article-title":"The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter","volume":"8","author":"Inoue","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2008.11.060_bib19","first-page":"92","article-title":"Surfing on prothymosin alpha proliferation and antiapoptotic properties","volume":"53","author":"Letsas","year":"2006","journal-title":"Neoplasma"},{"key":"10.1016\/j.urology.2008.11.060_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.urology.2005.08.034","article-title":"Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer","volume":"67","author":"Tzai","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.11.060_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.urology.2008.05.031","article-title":"Aberrant prothymosin-alpha expression in human bladder cancer","volume":"73","author":"Tsai","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.11.060_bib22","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1074\/jbc.M008560200","article-title":"Prothymosin alpha functions as a cellular oncoprotein by inducing transformation of rodent fibroblasts in vitro","volume":"276","author":"Orre","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2008.11.060_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1076807","article-title":"Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway","volume":"299","author":"Jiang","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.urology.2008.11.060_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/embo-reports\/kvf071","article-title":"Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription","volume":"3","author":"Karetsou","year":"2002","journal-title":"EMBO Rep"},{"key":"10.1016\/j.urology.2008.11.060_bib25","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/0008-5472.CAN-05-2112","article-title":"Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation","volume":"66","author":"Kobayashi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2008.11.060_bib26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.emboj.7600661","article-title":"Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha","volume":"24","author":"Lal","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.urology.2008.11.060_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-4827(02)00047-2","article-title":"Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha","volume":"284","author":"Evstafieva","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urology.2008.11.060_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yexcr.2004.04.008","article-title":"Interferon induces the interaction of prothymosin-alpha with STAT3 and results in the nuclear translocation of the complex","volume":"298","author":"Yang","year":"2004","journal-title":"Exp Cell Res"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:51:30Z","timestamp":1758765090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429509000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0090429509000260"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2008.11.060","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Relevance of Prothymosin-\u03b1 Expression in Human Upper Urinary Tract Transitional Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2008.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2008.12.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}